3.51 -0.17 (-4.61%)
VICL
| Trade VICL now with |
|
Stock Details
Last Trade:3.51 Change:-0.17 (-4.61%) Prev Close:3.68 Open: 3.69 Days Range:3.48 – 3.69 52 Week Range: 1.70 - 5.30 Volume:816746 P/E: N/AEPS:-0.11
View AllRecent Alerts 02/09/12
Recent Alert on 02/09/12 at 11:17am
Canaccord Genuity Maintains a 'Buy' on Vical (VICL); Still Attractive Risk/Reward
Canaccord Genuity Maintains a 'Buy' on Vical (VICL); Still Attractive Risk/Reward
Canaccord Genuity maintains a 'Buy' on Vical (NASDAQ: VICL) price target of $8.00. Analsyt, George Farmer, said, "Pushed out again, management sees overall survival data from the Phase III registration trial evaluating A-7 in metastatic melanoma... Read More
Recent Alert on 02/07/12 at 6:02pm
Trading Radar for 02/08: Sprint (S), Visa (V), Cisco (CSCO), Groupon (GRPN), News Corp (NWSA) Report
Trading Radar for 02/08: Sprint (S), Visa (V), Cisco (CSCO), Groupon (GRPN), News Corp (NWSA) Report
Recent Alert on 01/13/12 at 9:06am
Canaccord Biotech Meeting Takeaways Part II: NPSP, ONXX, TSRX, & VICL
Canaccord Biotech Meeting Takeaways Part II: NPSP, ONXX, TSRX, & VICL
Recent Alert on 01/06/12 at 10:53am
Morning Movers 01/06: (BDSI) (SABA) (XIDE) (AGEN) Higher; (DRRX) (RFMD) (IART) (PSMT) (SNTA) Lower
Morning Movers 01/06: (BDSI) (SABA) (XIDE) (AGEN) Higher; (DRRX) (RFMD) (IART) (PSMT) (SNTA) Lower
View AllRecent Press Releases
Press Release on 02/08/12 at 6:30am
Vical Reports 2011 Financial Results and Progress in Key Development Programs
Vical Reports 2011 Financial Results and Progress in Key Development Programs
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 01/31/12 at 10:45am
Vical's Allovectin: If Approved, What Kind Of Launch Can Be Expected?
Vical's Allovectin: If Approved, What Kind Of Launch Can Be Expected?